Chiron
Chiron Group, commonly referred to as Chiron, is a prominent player in the biotechnology and medical technology industry, headquartered in Germany (DE). Founded in the early 1990s, the company has established itself as a leader in the development of innovative solutions for the healthcare sector, particularly in the fields of diagnostics and therapeutic products. Chiron's core offerings include advanced diagnostic systems and biopharmaceuticals, distinguished by their cutting-edge technology and commitment to quality. With a strong presence in Europe and expanding operations globally, Chiron has achieved significant milestones, including strategic partnerships and product launches that have enhanced its market position. Recognised for its contributions to improving patient outcomes, Chiron continues to drive advancements in medical science, solidifying its reputation as a trusted name in the industry.
DitchCarbon Score
How does Chiron's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Motor Vehicle Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chiron's score of 25 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chiron's reported carbon emissions
In 2023, CHIRON Group SE reported total carbon emissions of approximately 6,259,000 kg CO2e globally. This figure includes about 2,467,000 kg CO2e from Scope 1 emissions, primarily from stationary combustion, and about 3,792,000 kg CO2e from Scope 2 emissions, which are attributed to purchased electricity. In 2022, the company's total emissions were higher, at about 7,568,000 kg CO2e, with Scope 1 emissions at approximately 3,776,000 kg CO2e and Scope 2 emissions at around 3,792,000 kg CO2e. Notably, CHIRON's Scope 3 emissions for 2022 were significant, reaching approximately 217,692,000 kg CO2e, with the use of sold products contributing the largest share. CHIRON has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 50% by 2028, using 2018 as the baseline year. Additionally, the company targets a 25% reduction in its absolute Scope 3 emissions within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and reflect CHIRON's commitment to addressing climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 1,510,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,792,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 000,000,000 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Chiron is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
